X
DXCM icon

Xponance’s DexCom DXCM Stock Holding History

Xponance’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.97M Sell
103,444
-2,644
-2% -$176K 0.04% 307
2026
Q1 		$6.66M Buy
106,088
+8,168
+8% +$569K 0.05% 293
2025
Q4 		$6.5M Buy
97,920
+5,021
+5% +$325K 0.05% 281
2025
Q3 		$6.25M Sell
92,899
-1,094
-1% -$86.6K 0.05% 282
2025
Q2 		$8.2M Buy
93,993
+3,771
+4% +$296K 0.07% 231
2025
Q1 		$6.16M Buy
90,222
+1,023
+1% +$83.5K 0.06% 256
2024
Q4 		$6.94M Sell
89,199
-948
-1% -$70.2K 0.06% 235
2024
Q3 		$6.04M Buy
90,147
+687
+0.8% +$56.4K 0.06% 255
2024
Q2 		$10.1M Buy
89,460
+2,141
+2% +$271K 0.1% 148
2024
Q1 		$12.1M Buy
87,319
+1,594
+2% +$200K 0.13% 138
2023
Q4 		$10.6M Sell
85,725
-2,878
-3% -$294K 0.13% 133
2023
Q3 		$8.27M Buy
88,603
+1,701
+2% +$192K 0.11% 155
2023
Q2 		$11.2M Buy
86,902
+1,842
+2% +$223K 0.15% 114
2023
Q1 		$9.88M Buy
85,060
+1,245
+1% +$139K 0.14% 127
2022
Q4 		$9.49M Buy
83,815
+5,389
+7% +$592K 0.15% 127
2022
Q3 		$6.32M Sell
78,426
-429
-0.5% -$36.3K 0.12% 150
2022
Q2 		$5.88M Sell
78,855
-2,005
-2% -$183K 0.12% 153
2022
Q1 		$10.3M Buy
80,860
+856
+1% +$93.6K 0.17% 96
2021
Q4 		$10.7M Buy
80,004
+20,968
+36% +$3.01M 0.17% 99
2021
Q3 		$8.07M Sell
59,036
-1,668
-3% -$210K 0.15% 120
2021
Q2 		$6.48M Buy
60,704
+5,916
+11% +$568K 0.12% 149
2021
Q1 		$4.92M Sell
54,788
-32
-0.1% -$3K 0.1% 171
2020
Q4 		$5.07M Buy
54,820
+1,016
+2% +$90.7K 0.11% 161
2020
Q3 		$5.54M Buy
53,804
+708
+1% +$74K 0.14% 134
2020
Q2 		$5.38M Buy
+53,096
New +$4.75M 0.14% 149

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Xponance's DXCM Position: Q2 2026 in Review

Xponance reduced its DexCom (DXCM) stake by 2.5% in Q2 2026, selling an estimated $176K and leaving 103,444 shares worth $6.97M. The position accounts for 0.04% of the portfolio, ranked #307.

Xponance first reported a position in DXCM in Q2 2020 and has held it in 25 quarters since. The position peaked at $12.1M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Xponance held 103,444 shares of DexCom worth $6.97M as of Q2 2026.
  • Xponance sold 2,644 DexCom shares in Q2 2026, an estimated $176K.
  • DexCom made up 0.04% of Xponance's portfolio in Q2 2026, its #307 holding.
  • Xponance first reported a position in DexCom in Q2 2020 and has held it in 25 quarters since.
  • Xponance's DexCom position peaked at $12.1M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.